The Mono Pharmacare IPO started on August 28, 2023, and ended on August 30, 2023. Shares were allocated on September 4, 2023, and refund processes began on September 5, 2023. On September 6, 2023, the shares were credited to investors demat accounts. Mono Pharmacare was officially listed on the stock exchange on September 7, 2023.
During the IPO, Mono Pharmacare offered shares at a price range of ₹26 to ₹28 per share, and the lot size was 4000 shares. The total issue size was ₹14.84 crores, with ₹14.84 crores from new shares. The IPO was listed on both the NSE SME.
Regarding share reservations, 10% of the shares were allocated to Qualified Institutional Buyers (QIB), 45% were reserved for Non-Institutional Investors (NII), and 45% were set aside for retail investors.
Mono Pharmacare Limited IPO Subscription Update Video
Mono Pharmacare IPO Subscription Status
The Mono Pharmacare IPO on August 30, 2023 was subscribed 13.42 times, with the retail category being subscribed 19.40 times, the NII (Non-Institutional Investor) category being subscribed 8.00 times, the QIB (Qualified-Institutional Buyers) category being subscribed 10.89 times.
| Category | Subscription |
| QIB | 10.89x |
| NII | 8.00x |
| Retail | 19.40x |
| Total | 13.42x |
Mono Pharmacare IPO Basic Details
| Company Name | Mono Pharmacare Limited |
| Domain of Company | Marketing and distribution of pharmaceutical products |
| IPO Open Date | August 28, 2023 |
| IPO Close Date | August 30, 2023 |
| IPO Allotment Date | September 4, 2023 |
| IPO Listing Date | September 7, 2023 |
| Face Value | ₹10 per share |
| Price | ₹26 to ₹28 per share |
| Lot Size | 4000 Shares |
| Issue Size | 5,300,000 shares of ₹10 (aggregating up to ₹14.84 Cr) |
| Fresh Issue | 5,300,000 shares of ₹10 (aggregating up to ₹14.84 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Company Promoters | Panilam Lakhatariya And Supal Lakhatariya |
About Mono Pharmacare Limited
Established in 1994, Mono Pharmacare Limited specializes in marketing and distributing pharmaceutical products. The company offers a wide range of healthcare products, including antibiotics, cough and cold remedies, antifungal medications, nutraceuticals, pain relievers, antacids, antiemetics, cardiac-diabetic drugs, and cosmocare products.
Mono Pharmacare collaborates with contract manufacturers to produce pharmaceutical items under the DLS Export brand name. In 2022, the company acquired DLS Export for ₹609 lakhs to expand its product portfolio in selected therapeutic areas.
As of February 28, 2023, the company boasts a network of more than 168 pharmaceutical company distributors and stockists. Additionally, it has catered to over 3,036 customers and vendors, encompassing both retail pharmacy outlets and wholesalers.
Mono Pharmacare IPO Should you subscribe?
Mono Pharmacare IPO More Details Click Here
Mono Pharmacare IPO FAQs
What is the start and end date of Mono Pharmacare IPO Subscription?
The Mono Pharmacare IPO started on August 28, 2023, and ended on August 30, 2023.
When does Mono Pharmacare IPO Subscription open?
The Mono Pharmacare IPO open on August 28, 2023.
When does Mono Pharmacare IPO Subscription close?
The Mono Pharmacare IPO Close on August 30, 2023.
What is the allotment date of Mono Pharmacare IPO?
The allotment date for Mono Pharmacare IPO is September 4, 2023.
When is the initial refund date of Mono Pharmacare IPO?
The initial Refund date for Mono Pharmacare IPO is September 5, 2023.
When were the shares credited to investors demat accounts for the Mono Pharmacare IPO?
The shares for the Mono Pharmacare IPO were credited to investors demat accounts on September 6, 2023.
When will Mono Pharmacare IPO be listed on the stock market?
Mono Pharmacare IPO stock market will be listed on September 7, 2023 at 10 am.
What was the price range of the Mono Pharmacare IPO shares?
The Mono Pharmacare IPO shares were offered at a price range of ₹26 to ₹28 per share.
What was the lot size for the Mono Pharmacare IPO shares?
The lot size for the Mono Pharmacare IPO shares was 4000 shares.
What was the total issue size of the Mono Pharmacare IPO?
The total issue size of the Mono Pharmacare IPO was ₹14.84 crores.
How were the shares allocated among different types of investors for the Mono Pharmacare IPO?
10% of the shares were allocated to Qualified Institutional Buyers (QIB), 45% were reserved for Non-Institutional Investors (NII), and 45% were set aside for retail investors.
On which stock exchanges was the Mono Pharmacare IPO listed?
The Mono Pharmacare IPO was listed on both the NSE SME.
What is the Mono Pharmacare IPO Subscription Status?
Mono Pharmacare IPO is subscribed 13.42 Times.
